These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 17570535

  • 1. Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A.
    Gartner T, Baeten M, Otieno S, Revets H, De Baetselier P, Huygen K.
    Immunol Lett; 2007 Jul 31; 111(1):26-35. PubMed ID: 17570535
    [Abstract] [Full Text] [Related]

  • 2. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, Huygen K.
    Vaccine; 2006 Apr 12; 24(16):3353-64. PubMed ID: 16488518
    [Abstract] [Full Text] [Related]

  • 3. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J, Tang Q, Yu F, Yang H, Zhao F, Xu W, Wang J, Hu W, Hu K, Liou C, Feng He X, Wang Y.
    Immunobiology; 2010 Apr 12; 215(2):133-42. PubMed ID: 19450898
    [Abstract] [Full Text] [Related]

  • 4. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
    Dou J, Wang Y, Yu F, Yang H, Wang J, He X, Xu W, Chen J, Hu K.
    Int J Immunogenet; 2012 Apr 12; 39(2):183-90. PubMed ID: 22152009
    [Abstract] [Full Text] [Related]

  • 5. [Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].
    Tang Q, Dou J, Zhao FS, Chu LL, Pan M, Wang YF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul 12; 23(7):591-4. PubMed ID: 17618574
    [Abstract] [Full Text] [Related]

  • 6. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
    Luo Y, Jiang W, Da Z, Wang B, Hu L, Zhang Y, An R, Yu H, Sun H, Tang K, Tang Z, Wang Y, Jing T, Zhu B.
    Scand J Immunol; 2012 Mar 12; 75(3):293-300. PubMed ID: 22117839
    [Abstract] [Full Text] [Related]

  • 7. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y.
    J Infect Dis; 2008 May 01; 197(9):1263-74. PubMed ID: 18422438
    [Abstract] [Full Text] [Related]

  • 9. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I, Udagawa T, Taniyama T.
    Tuberculosis (Edinb); 2007 Mar 01; 87(2):94-101. PubMed ID: 16815096
    [Abstract] [Full Text] [Related]

  • 10. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S, Gong Q, Wang C, Liu H, Wang Y, Guo S, Wang W, Liu J, Shao M, Chi L, Zhao K, Wang Z, Shi Y, Huang Y, Guli A, Zhang C, Kong X.
    Immunol Lett; 2008 May 15; 117(2):136-45. PubMed ID: 18339431
    [Abstract] [Full Text] [Related]

  • 11. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
    Deng YH, Sun Z, Yang XL, Bao L.
    Scand J Immunol; 2010 Oct 15; 72(4):332-8. PubMed ID: 20883318
    [Abstract] [Full Text] [Related]

  • 12. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y, Wang B, Hu L, Yu H, Da Z, Jiang W, Song N, Qie Y, Wang H, Tang Z, Xian Q, Zhang Y, Zhu B.
    Vaccine; 2009 Oct 19; 27(44):6179-85. PubMed ID: 19712772
    [Abstract] [Full Text] [Related]

  • 13. Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response.
    Wang D, Xu J, Feng Y, Liu Y, Mchenga SS, Shan F, Sasaki J, Lu C.
    Vaccine; 2010 Apr 19; 28(18):3134-42. PubMed ID: 20197133
    [Abstract] [Full Text] [Related]

  • 14. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.
    Tanghe A, D'Souza S, Rosseels V, Denis O, Ottenhoff TH, Dalemans W, Wheeler C, Huygen K.
    Infect Immun; 2001 May 19; 69(5):3041-7. PubMed ID: 11292722
    [Abstract] [Full Text] [Related]

  • 15. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.
    Vaccine; 2009 Nov 12; 27(48):6712-22. PubMed ID: 19733584
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 12; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
    Deng YH, He HY, Zhang BS.
    J Microbiol Immunol Infect; 2014 Feb 12; 47(1):48-56. PubMed ID: 23357605
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH, He HY, Zhang FJ.
    Scand J Immunol; 2013 Dec 12; 78(6):497-506. PubMed ID: 24283772
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z, Xian Q, Wang Y, Liu X, Zhu B.
    Scand J Immunol; 2011 Jun 12; 73(6):568-76. PubMed ID: 21323695
    [Abstract] [Full Text] [Related]

  • 20. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W, Li M, Deng G, Zhao L, Liu X, Wang Y.
    Mol Med Rep; 2015 Aug 12; 12(2):3073-80. PubMed ID: 25962477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.